The Europe Forensic Genomics Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
The capacity of next-generation sequencing to enable human identification using deteriorated blood samples, as well as its application in paternity testing, has caused a major increase in its usage. The precision of next-generation sequencing significantly lessens bias and errors. Rising investment and several biometrics-related projects to improve cybersecurity and efficiently handle forensic data provided by intelligence agencies have further increased the application of NGS.
Technology advancements are increasing test accuracy while lowering overall expenses. Forensic genomics is seeing a surge in demand for tests and applications that are more accurate and efficient as a result of the development of more cutting-edge technologies. Higher use of these techniques across government and corporate agencies is another outcome of greater and improved accuracy.
Cybercrimes and online fraud are on the rise as a result of improvements in Internet technology for digital data movement, communications, and storage of sensitive data. Another element that uses forensic genomics immensely is the rise in identity theft cases and unauthorized use of debit/credit card information.
In this region, the future of forensic genomics is being investigated through the research project CRIMTYP (CRIMinal Forensic Genomics PhenoTYPing). The University of Luxembourg's academic departments, law enforcement organizations, and private and public actors in the domain of genomics and next-generation sequencing are included in the initiative. With the development of new techniques, there are more options to use heritable phenotypic alterations and forensic DNA phenotyping (FDP), which estimates the externally evident traits of a person whose DNA was collected from the crime scene.
The Germany market dominated the Europe Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $67.3 Million by 2028.The UK market is anticipated to grow at a CAGR of 13.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 15% during (2022 - 2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Forensic Genomics Market will Hit $1 Billion by 2028, at a CAGR of 14.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
By Application
By Product
By Method
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
